180 related articles for article (PubMed ID: 19674968)
1. The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo.
Kriegs M; Bürckstümmer T; Himmelsbach K; Bruns M; Frelin L; Ahlén G; Sällberg M; Hildt E
J Biol Chem; 2009 Oct; 284(41):28343-28351. PubMed ID: 19674968
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice.
Kanda T; Steele R; Ray R; Ray RB
J Virol; 2009 Sep; 83(17):8463-9. PubMed ID: 19553305
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production.
Brenndörfer ED; Brass A; Söderholm J; Frelin L; Aleman S; Bode JG; Sällberg M
Gut; 2012 Apr; 61(4):589-96. PubMed ID: 21813471
[TBL] [Abstract][Full Text] [Related]
5. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
Holmström F; Pasetto A; Nähr V; Brass A; Kriegs M; Hildt E; Broderick KE; Chen M; Ahlén G; Frelin L
J Immunol; 2013 Feb; 190(3):1113-24. PubMed ID: 23284053
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
Bansal R; Frelin L; Brenndörfer ED; Storm G; Prakash J; Sällberg M
PLoS One; 2015; 10(6):e0128466. PubMed ID: 26030283
[TBL] [Abstract][Full Text] [Related]
7. Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses.
Fichter M; Piradashvili K; Pietrzak-Nguyen A; Pretsch L; Kuhn G; Strand S; Knuf M; Zepp F; Wurm FR; Mailänder V; Landfester K; Gehring S
Biomaterials; 2016 Nov; 108():1-12. PubMed ID: 27614817
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.
Frelin L; Brenndörfer ED; Ahlén G; Weiland M; Hultgren C; Alheim M; Glaumann H; Rozell B; Milich DR; Bode JG; Sällberg M
Gut; 2006 Oct; 55(10):1475-83. PubMed ID: 16527836
[TBL] [Abstract][Full Text] [Related]
9. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice.
Wang AG; Lee DS; Moon HB; Kim JM; Cho KH; Choi SH; Ha HL; Han YH; Kim DG; Hwang SB; Yu DY
J Pathol; 2009 Oct; 219(2):253-62. PubMed ID: 19621337
[TBL] [Abstract][Full Text] [Related]
10. Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses.
Holmström F; Chen M; Balasiddaiah A; Sällberg M; Ahlén G; Frelin L
Sci Rep; 2016 May; 6():24991. PubMed ID: 27141891
[TBL] [Abstract][Full Text] [Related]
11. Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A.
Hiet MS; Bauhofer O; Zayas M; Roth H; Tanaka Y; Schirmacher P; Willemsen J; Grünvogel O; Bender S; Binder M; Lohmann V; Lotteau V; Ruggieri A; Bartenschlager R
J Hepatol; 2015 Oct; 63(4):829-37. PubMed ID: 25908268
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice.
Majumder M; Steele R; Ghosh AK; Zhou XY; Thornburg L; Ray R; Phillips NJ; Ray RB
FEBS Lett; 2003 Dec; 555(3):528-32. PubMed ID: 14675768
[TBL] [Abstract][Full Text] [Related]
14. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
[TBL] [Abstract][Full Text] [Related]
15. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.
Sabri S; Idrees M; Rafique S; Ali A; Iqbal M
Int J Infect Dis; 2014 Aug; 25():38-44. PubMed ID: 24845365
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus NS5A protein enhances gluconeogenesis through upregulation of Akt-/JNK-PEPCK signalling pathways.
Kuo YC; Chen IY; Chang SC; Wu SC; Hung TM; Lee PH; Shimotohno K; Chang MF
Liver Int; 2014 Oct; 34(9):1358-68. PubMed ID: 25360475
[TBL] [Abstract][Full Text] [Related]
17. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
18. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
[TBL] [Abstract][Full Text] [Related]
19. In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.
Ahlen G; Nystrom J; Pult I; Frelin L; Hultgren C; Sallberg M
J Infect Dis; 2005 Dec; 192(12):2112-6. PubMed ID: 16288375
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.
Majumder M; Ghosh AK; Steele R; Zhou XY; Phillips NJ; Ray R; Ray RB
Virology; 2002 Mar; 294(1):94-105. PubMed ID: 11886269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
